PSMA and FDG PET/CT Findings in Patient With Dedifferentiated Liposarcoma and Prostate Cancer Metastases

Xuhe Liao; Hongwei Sun; Xueqi Chen; Yan Fan; Jianhua Zhang

doi:10.1097/RLU.0000000000005252

PSMA and FDG PET/CT Findings in Patient With Dedifferentiated Liposarcoma and Prostate Cancer Metastases

Clin Nucl Med. 2024 May 1. doi: 10.1097/RLU.0000000000005252. Online ahead of print.

Authors

Xuhe Liao¹, Hongwei Sun, Xueqi Chen, Yan Fan, Jianhua Zhang

Affiliation

¹ From the Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.

PMID: 38689438
DOI: 10.1097/RLU.0000000000005252

Abstract

Dedifferentiated liposarcoma is an extremely rare and highly malignant tumor. We demonstrated a case of a 75-year-old man with significantly PSMA-avid and mildly FDG uptake-dedifferentiated liposarcoma in the retroperitoneal area. The double-tracer (PSMA and FDG) PET scans could further contribute to differential diagnosis and the following treatment strategy for patients who were suspected with prostate cancer metastases and other malignant tumors simultaneously.